SEP
IBBQ icon

Signature Equity Partners’s Invesco NASDAQ Biotechnology ETF IBBQ Stock Holding History

Signature Equity Partners’s Portfolio IBBQ Stock Details IBBQ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$18.9K Sell
653
-1,177
-64% -$34.3K 0.01% 648
2025
Q4 		$52K Buy
+1,830
New +$49.8K 0.03% 392

Other funds holding IBBQ

LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
WG
WMS Group Folsom, Louisiana $68.8M AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
KAM
Knightsbridge Asset Management Newport Beach, California $743M AUM 28.33% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return

Signature Equity Partners's IBBQ Position: Q1 2026 in Review

Signature Equity Partners reduced its Invesco NASDAQ Biotechnology ETF (IBBQ) stake by 64% in Q1 2026, selling an estimated $34.3K and leaving 653 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #648.

Signature Equity Partners first reported a position in IBBQ in Q4 2025 and has held it in 2 quarters since. The position peaked at $52K in Q4 2025. 39 funds tracked by Wall St. Rank hold IBBQ as of Q1 2026.

  • Signature Equity Partners held 653 shares of Invesco NASDAQ Biotechnology ETF worth $18.9K as of Q1 2026.
  • Signature Equity Partners sold 1,177 Invesco NASDAQ Biotechnology ETF shares in Q1 2026, an estimated $34.3K.
  • Invesco NASDAQ Biotechnology ETF made up 0.01% of Signature Equity Partners's portfolio in Q1 2026, its #648 holding.
  • Signature Equity Partners first reported a position in Invesco NASDAQ Biotechnology ETF in Q4 2025 and has held it in 2 quarters since.
  • Signature Equity Partners's Invesco NASDAQ Biotechnology ETF position peaked at $52K in Q4 2025.
  • 39 funds tracked by Wall St. Rank held Invesco NASDAQ Biotechnology ETF as of Q1 2026.

Based on Signature Equity Partners's 13F filing for Q1 2026, filed 13 May 2026.